Author

F. Glickman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

C. Adura· 1 shared C. S. Krumm· 1 shared D. E. Cohen· 1 shared E. A. Ortlund· 1 shared J. D. Ginn· 1 shared L. Ramos-Espiritu· 1 shared M. Acuna· 1 shared M. C. Tillman· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. Adura

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-throughput screening identifies small molecule inhibitors of thioesterase superfamily member 1: Implications for the management of non-alcoholic fatty liver disease

C. S. Krumm, L. Ramos-Espiritu, R. S. Landzberg, C. Adura, X. Liu, M. Acuna, Y. Xie, X. Xu, M. C. Tillman, Y. Li, F. Glickman, E. A. Ortlund, J. D. Ginn, D. E. Cohen

This study identifies small molecule inhibitors of Them1, showing they enhance fatty acid oxidation and reduce glucose production in liver cells, suggesting therapeutic potential for NAFLD.

Molecular Metabolism · Dec 1, 2023Peer-reviewedPharmacology & Toxicology